TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.53
−2.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 28.16x
- P/S forward
- 2.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 33.18x
- Price / sales
- 4.82x
- Price / cash flow
- -7.42x
Enterprise value
- Enterprise value
- $205.5M
- EV / sales
- 4.56x
- EV / EBITDA
- -9.48x
- EV / EBIT
- -6.74x
- Market cap
- $217.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026